Gordon LG, Walker SM, Mervin MC, Lowe A, Smith DP, Gardiner RA, Chambers SK.
Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. European Journal of Cancer Care 2015. DOI: 10.1111/ecc.12392.
Baade PD, Yu XQ, Smith DP, Dunn J, Chambers SK.
Geographic disparities in prostate cancer outcomes: review of international patterns. Asian Pacific Journal of Cancer Prevention. 2015; 16(3):1259-1275.
Chambers SK, Lowe A, Hyde MK, Zajdlewicz L, Gardiner RA, Sandoe D, Dunn J.
Defining young in the context of prostate cancer. American Journal of Men’s Health. 2015; 9(2):103-114.
Gordon L, Tuffaha H, Scuffham P, Lowe A.
Health economic modelling for treatments and services in prostate cancer care: a master model for Australia. BJU International. 2015; 116: 13. (Published Abstract).
Chambers SK, Zajdlewicz L, Youlden DR, Holland JC, Dunn J.
The validity of the distress thermometer in prostate cancer populations. Psycho‐Oncology. 2014; 23(2):195-203
Chambers SK, Dunn J, Lazenby M, Clutton S, Newton RU, Cormie P, Lowe A, Sandoe D, Gardiner RA. ProsCare:
A psychological care model for men with prostate cancer [Monograph]. Prostate Cancer Foundation of Australia and Griffith University. November, 2013.
Gordon L.
Prostate cancer can be expensive and confusing. HealthCheck – The men’s health issue (GU internal publication), 2013, p. 11. Read More
